Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?

[1]  E. Vichinsky.  Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management , 2016, Current medical research and opinion.

[2]  J. Wood.  Estimating tissue iron burden: current status and future prospects , 2015, British journal of haematology.

[3]  S. Perrotta,et al.  Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload. , 2015, Blood.

[4]  M. Mrkobrada,et al.  A Systematic Review and Meta-Analysis of Deferiprone Monotherapy and in Combination with Deferoxamine for Reduction of Iron Overload in Chronically Transfused Patients with β-Thalassemia , 2014, Hemoglobin.

[5]  M. Marsella,et al.  Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease. , 2014, Hematology/oncology clinics of North America.

[6]  A. Taher,et al.  β-Thalassemia Intermedia: A Bird’s-Eye View , 2014, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[7]  Parth Parekh,et al.  Shear Wave Elastography for Evaluation of Liver Fibrosis , 2014, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  S. Bhandari,et al.  Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia. , 2013, Oman medical journal.

[9]  M. Cappellini,et al.  How I treat transfusional iron overload. , 2012, Blood.

[10]  T. Coates,et al.  Treating thalassemia major-related iron overload: the role of deferiprone , 2012, Journal of blood medicine.

[11]  K. Lau,et al.  Extra‐medullary haematopoiesis: A pictorial review of its typical and atypical locations , 2012, Journal of medical imaging and radiation oncology.

[12]  P. Brissot,et al.  Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years. , 2011, Gastroenterology.

[13]  S. Perrotta,et al.  Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. , 2011, Blood.

[14]  R. Lindeman,et al.  Australian guidelines for the assessment of iron overload and iron chelation in transfusion‐dependent thalassaemia major, sickle cell disease and other congenital anaemias , 2011, Internal medicine journal.

[15]  G. Abbate,et al.  Absence of teratogenicity of deferasirox treatment during pregnancy in a thalassaemic patient. , 2011, Pediatric endocrinology reviews : PER.

[16]  M. Drosou,et al.  Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®) , 2011, European journal of haematology.

[17]  G. Quarta,et al.  Pregnancy and β-thalassemia: an Italian multicenter experience , 2010, Haematologica.

[18]  K. Jones,et al.  Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias. , 2009, Clinical journal of oncology nursing.

[19]  J. Domingo,et al.  Assessment of the developmental toxicity of deferoxamine in mice , 2009, Archives of Toxicology.

[20]  P. Cianciulli.  Treatment of iron overload in thalassemia. , 2008, Pediatric endocrinology reviews : PER.

[21]  E. Gotsis,et al.  Rapid iron loading in a pregnant woman with transfusion-dependent thalassemia after brief cessation of iron chelation therapy , 2008, European journal of haematology.

[22]  E. Vichinsky,et al.  Deferoxamine treatment during pregnancy: Is it harmful? , 1999, American journal of hematology.

[23]  G. Koren,et al.  Counseling sexually active teenagers treated with potential human teratogens. , 1997, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[24]  Z. Sinakos,et al.  Transfusion-dependent homozygous beta-thalassaemia major: successful pregnancy in five cases. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[25]  F. Sullivan,et al.  The Consequences of Iron Overdose and its Treatment with Desferrioxamine in Pregnancy , 1991, Human & experimental toxicology.